Neurology

3 drugs are in development for Amyotrophic Lateral Sclerosis.

Companies: 2
Clinical trials: 38

BioSniper AIPage evidence connected

Prepared research question

Which programs lead the Amyotrophic Lateral Sclerosis pipeline—and what evidence could change the picture?

Run cited research

Traceable citations · Unknowns marked

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Pegcetacoplan (systemic)	Apellis Pharmaceuticals, Inc. (APLS)
Systemic pegcetacoplan	Apellis Pharmaceuticals, Inc. (APLS)

Phase 2(1)

Drug	Company
cnm-au8	Clene Inc. (CLNN)

About this indication

Amyotrophic Lateral Sclerosis context

Neurology·MeSH: Amyotrophic Lateral Sclerosis (D000690)

Also known as: ALS Amyotrophic Lateral Sclerosis, Charcot Disease, Disease, Lou-Gehrigs, Gehrig Disease, Gehrigs Disease, Lou Gehrig Disease, Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Incidence

2.0 / 100K/yr

Frequently asked questions

How many drugs are in development for Amyotrophic Lateral Sclerosis?

BioSniper tracks 3 drugs in development for Amyotrophic Lateral Sclerosis across 2 companies.

How many clinical trials target Amyotrophic Lateral Sclerosis?

There are 38 clinical trials targeting Amyotrophic Lateral Sclerosis tracked by BioSniper.